New York City, NY -- (SBWIRE) -- 12/02/2013 -- StockMarketIntel.com issues a special report on the following stocks: Alcoa Inc (NYSE:AA), NewLead Holdings Ltd (NASDAQ:NEWL), Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), dELiA*s, Inc. (NASDAQ:DLIA)
Alcoa Inc (NYSE:AA) declined -0.42% recently, while trading on 3.58 million shares at the price of $9.56. If we look at its trading history of the past 52 weeks, the share price suffered a low of $7.63 and was moved to its maximum level of $9.97.The stock changed hands in a range of $9.52 to $9.64, bringing its market capitalization at about $10.21 billion. Alcoa Inc. (Alcoa) is engaged in the production and management of primary aluminum, fabricated aluminum, and alumina combined, through its participation in technology, mining, refining, smelting, fabricating, and recycling. Alcoa’s products are used worldwide in aircraft, automobiles, commercial transportation, packaging, building and construction, oil and gas, defense, consumer electronics, and industrial applications.
Has AA Found The Bottom and Ready To Move Up? Find Out Here
NewLead Holdings Ltd (NASDAQ:NEWL) declined -8.11% recently, in the current trading session, at $0.680 with a total volume of 242,656 shares. The stock, on average, trades on a volume of 775,782 shares. In the past 52 weeks, the share price has not declined below $0.53 and above $40.95.It floated in a range of $0.63 to $0.76 during the recent trading session, with a beta value of 1.21.Its market capitalization now moved to about $18.00 million. NewLead Holdings Ltd. (NewLead) is an international shipping company engaged in the transportation of refined products, such as gasoline and jet fuel, and dry bulk goods, such as iron ore, coal and grain. NewLead operates in two segments: wet operations, which consists of tankers transporting several different refined petroleum products simultaneously in segregated, coated cargo tanks, and dry operations, which consists of transportation and handling of bulk cargoes through ownership, operation and trading of vessels.
Has NEWL Found The Bottom And Ready To Gain Momentum? Find Out Here
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) recently recorded a gain of 4.65% and was moving within a range of $1.71-$1.81. Its current trading price is $1.79. The share price hit its 52-week low of $0.41 and $3.65 was the best price. The stock completed the day with a total volume of 363,763 shares, versus an average volume of 1.97 million shares. Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy. As of December 31, 2011, the Company had two drugs in development: CPP-109 and CPP-115.
Why Should Investors Buy CPRX After The Recent Gain? Just Go Here and Find Out
dELiA's, Inc. (NASDAQ:DLIA) declined -5.83% in its current trading activity, bringing its market capitalization around $54.21 million. The total number of shares that changed hands during the current session up till now was 533,185 shares, as compared to average trading volume of 1.28 million shares. The share price after opening at $1.20 made a high of $1.23 and hovered above $1.13, while its recent trading price was $1.13. dELiA*s, Inc. is a retail company comprised of two lifestyle brands primarily targeting teenage girls and young women. The Company generates revenue by selling predominantly to teenage consumers through direct mail catalogs, Websites and retail stores. It operates in dELiA*s brand. Through its e-commerce Webpages, catalogs and retail stores, dELiA*s (the brand) offers a variety of product categories to teenage girls to cater to an entire lifestyle. Through its catalogs and the e-commerce Webpages, it sells many name brand products along with its own brand products in key teenage spending categories.
Will DLIA Get Buyers Even After The Recent Rally? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)